Skip to main content

Table 1 Demographic data and laboratory results of the studied groups

From: Study of serum bisphenol-A and the mRNA of galactosidase beta 1 and tumor necrosis factor alpha in Egyptian patients with type 2 diabetes mellitus

 

Control (n = 30)

T2DM (n = 60)

p

Sex

 Male

15 (50%)

33 (55%)

0.654

 Female

15 (50%)

27 (45%)

Age (years)

53.63 ± 7.63

58.53 ± 6.56

 < 0.001*

BMI (kg/m2)

24.07 ± 2.39

29.77 ± 3.98

 < 0.001*

Waist circumference (cm)

82.57 ± 8.41

93.97 ± 9.04

 < 0.001*

Systolic blood pressure (mmHg)

110.7 ± 10.15

114.7 ± 12.41

0.130

Diastolic blood pressure (mmHg)

79.67 ± 9.28

81.17 ± 8.65

0.451

Mean arterial blood pressure

90.0 ± 7.17

92.33 ± 8.08

0.184

AST (U/L)

25.87 ± 6.54

29.68 ± 16.22

0.298

ALT (U/L)

28.77 ± 12.91

31.0 ± 6.70

0.140

Albumin (g/dl)

3.83 ± 0.85

3.50 ± 0.86

0.088

Urea (mg/dl)

15.73 ± 4.63

24.02 ± 19.01

0.111

Serum creatinine (mg/d)

1.10 ± 0.17

1.60 ± 1.79

0.264

e-GFR (ml/min/1.7)

72.53 ± 16.05

69.69 ± 32.61

0.581

UACR (mcg/mg creat.)

16.46 ± 4.16

16.35 ± 3.36

0.885

Total cholesterol (mg/dl)

171.8 ± 17.27

172.4 ± 16.91

0.890

HDL (mg/dl)

70.67 ± 7.48

69.25 ± 7.02

0.380

TG (mg/dl)

140.8 ± 10.15

143.6 ± 7.87

0.179

LDL (mg/dl)

72.97 ± 21.32

74.43 ± 17.93

0.734

Fasting glucose level (mg/dl)

102.6 ± 14.28

113.7 ± 22.34

0.005*

HbA1c (%)

4.97 ± 0.66

7.09 ± 1.21

 < 0.001*

Fasting insulin level (mU/L)

6.85 ± 3.23

12.90 ± 11.18

0.044*

Insulin resistance (HOMA-IR)

1.74 ± 0.88

3.86 ± 3.49

0.042*

  1. AST aspartate aminotransferase. ALT alanine aminotransferase. e-GFR estimated glomerular filtration rate. UACR urinary albumin creatinine ratio. HDL high-density lipoproteins. TG triglycerides. LDL low-density lipoproteins. Quantitative data was expressed using mean ± SD. SD standard deviation. p p-value for comparing between the studied groups. *Statistically significant at p ≤ 0.05